Title:
新規アニリン誘導体
Document Type and Number:
Japanese Patent JP2004504280
Kind Code:
A
Abstract:
The present invention relates to compounds of formula (I)wherein U, Y, V, W, L, X, A<1>, A<2>, A<3>, A<4>, A<5 >and A<6 >are as defined in the description and claims and pharmaceutically acceptable salts and/or pharmaceutically acceptable esters thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, and/or treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
More Like This:
| WO/1995/004713 | 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS |
| JP5212931 | Method for producing lasophoxyphene and its analogs |
| WO/1999/016746 | AMINOALKYLPHENOL DERIVATIVES AND RELATED COMPOUNDS |
Inventors:
Ackerman, Jean
Shrimp, Johannes
Kukorowski, Alexander
Henrietta, Damelow
Moran, Olivier
Valbaum, Sabine
Thomas Weller
Shrimp, Johannes
Kukorowski, Alexander
Henrietta, Damelow
Moran, Olivier
Valbaum, Sabine
Thomas Weller
Application Number:
JP2002512096A
Publication Date:
February 12, 2004
Filing Date:
July 11, 2001
Export Citation:
Assignee:
F. HOFFMANN-LA ROCHE AKTIENGESELLSCHAFT
International Classes:
C07D295/08; A61K31/16; A61K31/17; A61K31/18; A61K31/27; A61K31/33; A61K31/381; A61K31/40; A61K31/404; A61K31/42; A61K31/44; A61K31/445; A61K31/47; A61K31/495; A61K31/5375; A61K31/54; A61K31/55; A61P1/16; A61P3/06; A61P3/10; A61P9/00; A61P9/10; A61P31/10; A61P33/00; A61P35/00; C07C231/02; C07C233/29; C07C233/75; C07C235/56; C07C235/84; C07C255/57; C07C269/04; C07C271/28; C07C271/58; C07C273/06; C07C275/34; C07C275/36; C07C275/38; C07C303/38; C07C307/10; C07C311/13; C07C311/21; C07C311/29; C07C323/44; C07C333/08; C07C335/18; C07C335/22; C07D207/14; C07D207/20; C07D209/42; C07D211/14; C07D211/22; C07D211/42; C07D211/46; C07D211/70; C07D213/75; C07D213/81; C07D213/82; C07D215/36; C07D215/40; C07D239/42; C07D261/10; C07D295/092; C07D307/14; C07D307/52; C07D317/58; C07D319/18; C07D333/24; C07D333/34; C07D333/38; (IPC1-7): C07C233/75; A61K31/17; A61K31/18; A61K31/27; A61K31/381; A61K31/40; A61K31/404; A61K31/42; A61K31/44; A61K31/445; A61K31/47; A61K31/495; A61K31/5375; A61K31/54; A61K31/55; A61P1/16; A61P3/06; A61P3/10; A61P9/00; A61P9/10; A61P31/10; A61P33/00; A61P35/00; C07C231/02; C07C269/04; C07C271/28; C07C271/58; C07C273/06; C07C275/36; C07C303/38; C07C307/10; C07C311/21; C07C333/08; C07C335/18; C07D207/14; C07D209/42; C07D211/14; C07D211/46; C07D211/70; C07D215/40; C07D261/10; C07D295/08; C07D333/34
Attorney, Agent or Firm:
Hajime Tsukuni
Fumio Shinoda
Fumio Shinoda